CTSA Program Posters

Regulatory Science is defined by the US Food and Drug Administration (FDA) as “the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality and performance of FDA-regulated products” that ultimately enhances the overall translational research process and improves the development of safe and effective medical interventions. Precision medicine holds

From the first days after COVID-19 reached our nation’s shores, Tufts CTSI has taken an active role in helping researchers at Tufts Medical Center (Tufts MC), Tufts University, and its partners and collaborators to respond to the pandemic. Located in Boston, an early COVID-19 “hot-spot,” and seeing that the pandemic could be stopped only through clinical and translational research, Tufts CTSI

The UC Davis CTSC applied the CTSA program goals to assist the division of pulmonary and sleep medicine with the recruitment, examination, and treatment of a diverse array of participants into an industry-funded COVID-19 vaccine trial. The project encompassed all five of the CTSA program goals and resulted in a robust study population. The first 80 subjects were recruited, screened, and scheduled

The dissemination of the I-Corps@NCATS program has accelerated the development and commercialization of breakthrough innovations in medical research across U. Miami and the CTSA partner hubs. Taking the lessons from the “I-Corps at the CTSA Train-The-Trainer pilot initiative” in 2017, nine participants developed the I-Corps@NCATS program with support from a CTSA Administrative Supplement to

Since 2015, the two Los Angeles-based CTSA hubs have partnered with the Los Angeles County Department of Health Services (DHS) to foster partnered implementation research in the DHS delivery system. Service cores and a competitive pilot award supported team-based research that address Health Agency priorities. The partners developed review criteria to encompass scientific value and suitability of

Study Purpose/Aim The aim of this study was to report the intrapartum care experiences from people giving birth during the COVID-19 pandemic. Research Questions Studies that involved patient-related data collection are hindered by pandemic-related changes in clinical practices and research policies. Our aim was to assess patient experience during a pandemic, we explored data collection via a large

The rate at which COVID-19 spread required a rapid response across many, if not all, industries. Academic medical centers had to rapidly evaluate, prioritize, and coordinate the multiple requests for clinical trial participation. This involved redirecting resources and the development of a collaborative system for assessment, decision making, and implementation. Our institution formed a team with

In 2021 at the start of its 4th CTSA award, the UC Davis Clinical and Translational Science Center (CTSC) created the Health Equity Resources & Outreach (HERO) program. The newly formed team is poised to support clinician scientists and community researchers to innovate, collaborate, and expand health equity research. The Health Informatics (HI) Research Data Officer helps to identify and link

The UI Mobile Technology Lab supports CTSA efforts by providing easy-to-use and scalable approaches for remotely collecting data from patients in their home environment. Our lab has custom software to ask participants questions and aggregate information collected from mobile and IoT wellness devices. We use both off-the-shelf (eg, Fitbits, thermometers, microphones and image sensors) as well as